Tissue distribution of YM758, a novel If channel inhibitor, in pregnant and lactating rats

References

• Behravan J, Piquette-Miller M. Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opinion on Drug Metabolism and Toxicology 2007; 3: 819–830
   PubMed Web of Science ®Google Scholar
• Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: An overview of epidemiological (drug utilization) studies. European Journal of Clinical Pharmacology 1990; 38: 325–328
   PubMed Web of Science ®Google Scholar
• Bucchi A, Barbuti A, Baruscotti M, DiFrancesco D. Heart rate reduction via selective ‘funny’ channel blockers. Current Opinion in Pharmacology 2007; 7: 208–213
   PubMed Web of Science ®Google Scholar
• Buckberg GD, Fixler DE, Archie JP, Hoffman JI. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circulation Research 1972; 30: 67–81
   PubMed Web of Science ®Google Scholar
• Grube M, Reuther S, Meyer Zu Schwabedissen H, Köck K, Draber K, Ritter CA, Fusch C, Jedlitschky G, Kroemer HK. Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta. Drug Metabolism and Disposition 2007; 35: 30–35
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K. Citalopram in pregnancy and lactation. Clinical Pharmacology and Therapeutics 2002; 72: 184–191
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ekblad U, Palo P, Laine K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clinical Pharmacology and Therapeutics 2003; 73: 330–337
   PubMed Web of Science ®Google Scholar
• Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). Journal of Biological Chemistry 2000; 275: 2905–2910
   PubMed Web of Science ®Google Scholar
• Indolfi C, Guth BD, Miura T, Miyazaki S, Schulz R, Ross J, Jr. Mechanisms of improved ischaemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine. Circulation 1989; 80: 983–993
   PubMedGoogle Scholar
• Jonker JW, Merino G, Musters S, Van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, Schinkel AH. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Medicine 2005; 11: 127–129
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 2001; 120: 525–533
   PubMed Web of Science ®Google Scholar
• Lankas GR, Wise LD, Cartwright ME, Pippert T, Umbenhauer DR. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reproductive Toxicology 1998; 12: 457–463
   PubMed Web of Science ®Google Scholar
• Laurent D, Bolene-Williams C, Williams FL, Katz LN. Effects of heart rate on coronary flow and cardiac oxygen consumption. American Journal of Physiology 1956; 185: 355–364
   PubMed Web of Science ®Google Scholar
• Matt DW, Borezelleca JF. Toxic effects on the female reproductive system during pregnancy, parturition, and lactation. Reproductive toxicology, RJ Witorsch. Raven, New York, NY 1995; 175–196
   Google Scholar
• Nagata Y, Kusuhara H, Hirono S, Endou H, Sugiyama Y. Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3. Drug Metabolism and Disposition 2004; 32: 1040–1047
   Google Scholar
• Ohta K, Fukasawa Y, Yamaguchi J, Kohno Y, Fukushima K, Suwa T, Awazu S. Retention mechanism of imidazoles in connective tissue. IV. Identification of a nucleophilic imidazolone metabolite in rats. Biological and Pharmaceutical Bulletin 1998; 21: 1334–1337
   PubMedGoogle Scholar
• Oitate M, Hirota T, Koyama K, Inoue S, Kawai K, Ikeda T. Covalent binding of radioactivity from [14C]rofecoxib, but not [14C]celecoxib or [14C]CS-706, to the arterial elastin of rats. Drug Metabolism and Disposition 2006; 34: 1417–1422
   PubMed Web of Science ®Google Scholar
• Oitate M, Hirota T, Murai T, Miura S, Ikeda T. Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to allysine aldehyde in elastin of human aorta. Drug Metabolism and Disposition 2007a; 35: 1846–1852
   PubMed Web of Science ®Google Scholar
• Oitate M, Hirota T, Takahashi M, Murai T, Miura S, Senoo A, Hosokawa T, Oonishi T, Ikeda T. Mechanism for covalent binding of rofecoxib to elastin of rat aorta. Journal of Pharmacology and Experimental Therapeutics 2007b; 320: 1195–1203
   PubMed Web of Science ®Google Scholar
• Oo CY, Paxton EW, McNamara PJ. Active transport of nitrofurantoin into rat milk. Advances in Experimental Medicine and Biology 2001; 501: 547–552
   Google Scholar
• Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, Schinkel AH. Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. Journal of Pharmacology and Experimental Therapeutics 2005; 312: 144–152
   PubMed Web of Science ®Google Scholar
• Roth W, Bauer E, Heinzel G, Cornelissen PJ, Van Tol RG, Jonkman JH, Zuiderwijk PB. Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects. Journal of Pharmaceutical Sciences 1993; 82: 99–106
   PubMed Web of Science ®Google Scholar
• Sastry BV. Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions, and placental function. Reproduction, Fertility, and Development 1991; 34: 355–372
   Google Scholar
• Sonnenblick EH, Ross J, Jr, Braunwald E. Oxygen consumption of the heart. Newer concepts of its multifactoral determination. American Journal of Cardiology 1968; 22: 328–336
   PubMed Web of Science ®Google Scholar
• Umehara KI, Iwai M, Adachi Y, Usui T, Iwatsubo T, Usui T, Kamimura H. Hepatic uptake and excretion of (–)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel if channel inhibitor, in rats and humans. Drug Metabolism and Disposition 2008b; 36: 1030–1038
   Google Scholar
• Umehara KI, Iwatsubo T, Noguchi K, Kamimura H. Comparison of kinetic characteristics of inhibitory effects by biguanides and H2-blockers on the organic cation transporters-mediated transport between human (OCT) and rat (oct): Insight into the application to the development of drug candidates. Xenobiotica 2007; 37: 618–634
   PubMed Web of Science ®Google Scholar
• Umehara KI, Seya K, Sonoda T, Nakamura E, Noguchi K, Usui T, Kamimura H. Comparative evaluation of absorption, distribution, and excretion of YM758, a novel If channel inhibitor, between albino and non-albino rats. Xenobiotica 2008a; 38: 527–539
   PubMed Web of Science ®Google Scholar
• Wilson JG. Current status of teratology. Handbook of teratology, JG Wilson, FC Fraster. Plenum, New York, NY 1977; 47
   Google Scholar
• Young AM, Allen CE, Audus KL. Efflux transporters of the human placenta. Advanced Drug Delivery Reviews 2003; 55: 125–132
   PubMed Web of Science ®Google Scholar